NO971453L - Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer - Google Patents

Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer

Info

Publication number
NO971453L
NO971453L NO971453A NO971453A NO971453L NO 971453 L NO971453 L NO 971453L NO 971453 A NO971453 A NO 971453A NO 971453 A NO971453 A NO 971453A NO 971453 L NO971453 L NO 971453L
Authority
NO
Norway
Prior art keywords
treatment
drugs
manufacture
liver diseases
chronic
Prior art date
Application number
NO971453A
Other languages
English (en)
Other versions
NO971453D0 (no
Inventor
Gerhard Breipohl
Stephan Henke
Jochen Knolle
Klaus Wirth
Max Hropot
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO971453D0 publication Critical patent/NO971453D0/no
Publication of NO971453L publication Critical patent/NO971453L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske leversykdommer (leverzirrhose og leverfibrose) og akutte leversykdommer, og for forhindring av komplikasjoner, spesielt for proiylakse henholdsvis behandling av portal hypertoni, dekompensasjonsfiemkomster som aszites, ødemdannelse, hepatorenaJt syndrom, hypertensiv gastro- og cholopati, splenomegali samt blødningskomplikasjoner i mage-tarm-kanalen ved portal hypertoni, kollateralt kretsløp og hyperemi og en kardiopati som følge av en kronisk hyperdynam kretsløp- situasjon og fialger derav, er beskrevet.
NO971453A 1996-03-27 1997-03-26 Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer NO971453L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19612067A DE19612067A1 (de) 1996-03-27 1996-03-27 Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Publications (2)

Publication Number Publication Date
NO971453D0 NO971453D0 (no) 1997-03-26
NO971453L true NO971453L (no) 1997-09-29

Family

ID=7789557

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971453A NO971453L (no) 1996-03-27 1997-03-26 Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer

Country Status (24)

Country Link
US (1) US5863901A (no)
EP (1) EP0797997B1 (no)
JP (1) JP4185169B2 (no)
KR (1) KR100453394B1 (no)
CN (1) CN1164421A (no)
AT (1) ATE297749T1 (no)
AU (1) AU1651697A (no)
BR (1) BR9701455A (no)
CA (1) CA2200040A1 (no)
CZ (1) CZ90797A3 (no)
DE (2) DE19612067A1 (no)
DK (1) DK0797997T3 (no)
ES (1) ES2242973T3 (no)
HR (1) HRP970171A2 (no)
HU (1) HUP9700642A3 (no)
ID (1) ID16413A (no)
IL (1) IL120521A0 (no)
NO (1) NO971453L (no)
PL (1) PL319193A1 (no)
PT (1) PT797997E (no)
SI (1) SI0797997T1 (no)
SK (1) SK39297A3 (no)
TR (1) TR199700228A2 (no)
ZA (1) ZA972599B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽ｂ２受體調節劑
CA2728766A1 (en) * 2008-06-20 2009-12-23 Kinemed, Inc. Compositions for the treatment of fibrotic diseases or conditions
EP3998259A1 (en) 2017-11-24 2022-05-18 Pharvaris Netherlands B.V. Novel bradykinin b2 receptor antagonists
AR118983A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
WO1989009230A1 (en) * 1988-03-25 1989-10-05 Administrators Of The Tulane Educational Fund Therapeutic peptides
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
WO1991009055A1 (en) * 1989-12-08 1991-06-27 Boston University Acylated bradykinin antagonists and uses therefor
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina
CA2106677A1 (en) * 1991-04-01 1992-10-02 John C. Cheronis Bradykinin antagonists
JPH07504155A (ja) * 1991-04-19 1995-05-11 シオス・ノヴァ・インコーポレイテット ブラジキニンアンタゴニストペプチド
WO1992018155A1 (en) * 1991-04-19 1992-10-29 Nova Technology Limited Partnership Bradykinin type peptides
WO1993011789A1 (en) * 1991-12-12 1993-06-24 Scios Nova Inc. Modified position (7) bradykinin antagonist peptides
FR2686343B1 (fr) * 1992-01-17 1994-03-11 Adir Cie Nouveaux derives pseudopeptidiques a activite antagoniste de la bradykinine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
TW258739B (no) * 1992-04-04 1995-10-01 Hoechst Ag
FR2692581B1 (fr) * 1992-06-18 1994-08-19 Adir Nouveaux dérivés peptidiques à activité antagoniste de la bradykinine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
AU5098593A (en) * 1992-09-11 1994-04-12 Lajos Gera Bradykinin antagonists containing aliphatic amino acids in the 5-position
US5521158A (en) * 1992-10-08 1996-05-28 Scios Nova Inc. Pseudopeptide bradykinin receptor antagonists
IL107400A0 (en) * 1992-11-10 1994-01-25 Cortech Inc Bradykinin antagonists
WO1994019372A1 (en) * 1993-02-17 1994-09-01 Scios Nova Inc. Cyclic bradykinin antagonist peptides
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
EP0716661B1 (en) * 1993-09-09 2000-04-05 Scios Inc. Pseudo- and non-peptide bradykinin receptor antagonists
DE4345062A1 (de) * 1993-12-31 1995-07-13 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von Viruserkrankungen
KR100360639B1 (ko) * 1994-03-09 2003-01-30 코르텍, 인크. N-치환글리신함유브라디키닌길항제펩티드

Also Published As

Publication number Publication date
HRP970171A2 (en) 1998-04-30
US5863901A (en) 1999-01-26
JPH1017491A (ja) 1998-01-20
EP0797997B1 (de) 2005-06-15
HUP9700642A2 (hu) 1998-01-28
AU1651697A (en) 1997-10-02
SI0797997T1 (en) 2005-10-31
DE19612067A1 (de) 1997-10-02
PT797997E (pt) 2005-09-30
CZ90797A3 (en) 1997-10-15
DE59712344D1 (de) 2005-07-21
KR100453394B1 (ko) 2004-12-30
JP4185169B2 (ja) 2008-11-26
CA2200040A1 (en) 1997-09-27
ZA972599B (en) 1997-09-29
IL120521A0 (en) 1997-07-13
EP0797997A2 (de) 1997-10-01
PL319193A1 (en) 1997-09-29
EP0797997A3 (de) 2000-05-31
ID16413A (id) 1997-09-25
DK0797997T3 (da) 2005-10-17
MX9702292A (es) 1997-09-30
BR9701455A (pt) 1998-08-18
NO971453D0 (no) 1997-03-26
SK39297A3 (en) 1997-10-08
TR199700228A2 (xx) 1997-10-21
ATE297749T1 (de) 2005-07-15
CN1164421A (zh) 1997-11-12
HU9700642D0 (en) 1997-05-28
ES2242973T3 (es) 2005-11-16
HUP9700642A3 (en) 1998-03-02
KR970064622A (ko) 1997-10-13

Similar Documents

Publication Publication Date Title
NO972311L (no) Anvendelse av ikke-peptidiske Bradykinin-antagonister for behandling og prevensjon av kronisk fibrogenetiske leversykdommer, akutte leversykdommer og de dermed forbundne komplikasjoner
NO993979L (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
CO4970694A1 (es) Amlodipino y atorvastatina utiles en el tratamiento de angina de pecho, ateroesclerosis, hipertension e hiperlipidemia
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
NO884840D0 (no) Fremgangsmaate for behandling av underjordiske formasjoner med gelfluider som gir forsinket kryssbinding.
NO971453L (no) Anvendelse av bradykinin-antagonister for fremstilling av legemidler for behandling av kroniske fibrogenetiske og akutte leversykdommer
WO2003035174A3 (en) System and/or method for refibrillation of the heart for treatment of post-countershock pulseless electrical activity and/or asystole.
IN170898B (no)
NO984759L (no) Anvendelse av en osmolytt ved fremstilling av et medikament for behandling av komplikasjoner forÕrsaket av iskemi
FI973184A0 (fi) Kombinaatioterapia HIV-infektiota varten käyttäen HIV-proteaasi-inhibiittoria indinavir ja käänteistranskriptaasi-inhibiittoria 3TC, mahdollisesti yhdessä AZT:n, DDI:n tai DDC:n kanssa
ES2046246T3 (es) Composicion terapeutica para combatir el sida.
IT235676Y1 (it) Allestimenti per lo svolgimento del gioco wormhole action match.
NO20012423L (no) Antikonvulsjonsmiddelderivater som er nyttige ved behandling av posttraumatiske stresslidelser
ATE253923T1 (de) Verhütung von magen-darm schäden
RU2001115900A (ru) Способ лечения туберкулеза легких
NO974956L (no) Terapeutisk sammensetning for artritis
AR007209A1 (es) Utilizacion de antagonistas de bradiquinina no peptidicos para la preparacion de medicamentos utiles para el tratamiento y la prevencion deenfermedades hepaticas cronicas y fibrogeneticas, enfermedades hepaticas agudas y las complicaciones asociadas a ella
ES2117386T3 (es) Procedimiento para la obtencion de un revestimiento de asfalto de dos capas.
RU97113115A (ru) Пелоидотерапия
UA40384A (uk) Спосіб лікування хронічного гнійного верхньощелепного синуїту
ES2084566B1 (es) Locion capilar y procedimiento para su fabricacion.
Slavid Intimacy and light transform basement dining
RU2002120397A (ru) Способ лечения и профилактики тромбоэмболии лёгочной артерии
RU2002134849A (ru) Способ лечения острых послеродовых эндометритов у коров
RU2001108719A (ru) Способ профилактики побочных эффектов для препарата фенилина при лечении тромбозов и эмболий